OTARMENI 30000000000000 {GC}/mL
lunsotogene parvec · INJECTION, SOLUTION · Regeneron Pharmaceuticals, Inc.
OTARMENI is a injection, solution containing lunsotogene parvec at 30000000000000 {GC}/mL, taken intracochlear. Manufactured by Regeneron Pharmaceuticals, Inc..
Key Facts
- Brand Name
- OTARMENI
- Generic Name
- lunsotogene parvec
- NDC Code (Product)
61755-062- Manufacturer
- Regeneron Pharmaceuticals, Inc.
- Strength
- 30000000000000 {GC}/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRACOCHLEAR
- Marketing Status
- Application #
- BLA125874
- Marketing Start
- 04/23/2026
Recall History
No Recall HistoryFrequently Asked Questions
What is OTARMENI used for?
OTARMENI contains lunsotogene parvec. It is a injection, solution taken intracochlear. Consult your doctor for specific uses.
Is OTARMENI a controlled substance?
OTARMENI is not classified as a controlled substance by the DEA.
What is the generic name for OTARMENI?
The generic name for OTARMENI is lunsotogene parvec. There are no other listed brand versions of lunsotogene parvec.
What is the NDC code for OTARMENI 30000000000000 {GC}/mL?
The NDC (National Drug Code) for OTARMENI 30000000000000 {GC}/mL is 61755-062, listed by Regeneron Pharmaceuticals, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)